genekor

15 March, 2023

CNV and RNA analysis reveal a germline pathogenic duplication of MSH2 exon 15 in a family with Lynch syndrome: A case report

The new publication of the Genekor Scientific Team on: CNV and RNA analysis reveal a germline pathogenic duplication of MSH2 exon 15 in a family with Lynch syndrome: A case […]

25 January, 2023

Molecular Residual Disease – Publication of the GALAXY Study

On Monday, January 16th, Nature Medicine published the first results of the observational study (GALAXY study), which is one of the 3 arms of the prospective study (CIRCULATE Japan). Important […]

23 December, 2022

70% of relatives of patients with pathogenic genes do not undergo genetic testing

Nikos Tsoulos, CEO of Genekor I.A.E., gave an interview to THE DOCTOR magazine on the importance of genetic testing in relatives of people who have been diagnosed with breast and […]

15 December, 2022

Polygenic Risk Score in a cohort of 105 Breast Cancer patients previously tested with a multi gene panel for hereditary cancer

The study by the Genekor Scientific Team on “ The study by the Genekor Scientific Team on “Polygenic Risk Score in a cohort of 105 Breast Cancer patients previously tested […]

30 November, 2022

Sanofi – Genekor collaboration for the early diagnosis of patients with rare diseases

More than 7,000 rare diseases that affect more than 300,000,000 people around the world have been identified in recent years. This fact causes the need to use particularly innovative diagnostic […]

15 September, 2022

Next Generation Sequencing (NGS) for the identification of PARP inhibitors’ predictive biomarkers

Another important study by the Genekor Scientific Team on “Next Generation Sequencing (NGS) for the identification of PARP inhibitors’ predictive biomarkers” was presented by Dr. Floros Ir. Theofanis (Oncologist Pathologist, […]

13 September, 2022

Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes

The study by the Genekor Scientific Team on “Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes” was presented at ESMO CONGRESS […]

23 August, 2022

The CureHeart Project -Team of experts from UK, US and Singapore to design jab to save thousands of lives by rewriting DNA

Cardiomyopathies are “really common” and affected one person in every 250 around the world, said Prof Hugh Watkins, from the University of Oxford and lead investigator of the CureHeart project. […]

17 August, 2022

10 tips to protect your skin from the sun.

A recent study showed that only 14% of men and 30% of women regularly put sunscreen on their face and other exposed body parts before going out for more than […]

Search